WuXi Biologics has successfully launched the GMP operation of its new drug product facility in Wuxi, China, which is the eighth operational drug product facility in company’s global network.   The 12,000m² drug product facility, called DP2, features a state-of-the-art isolator filling line for the continuous high-speed production of a wide range of sizes – from 2R to 50R of liquid and 20m2/40m2 of lyophilization. The facility can switch rapidly between different specifications to maximize its ...